The Board oversees the work of SIOPE and provides guidance in administering the organisation. It meets approximately every month, to discuss the priorities and issues at stake and agree on a joint approach to problem solving. More specifically, the role of the SIOPE Board is to:
- Provide strategic advice on paediatric oncology in Europe;
- Define priorities and targets of the organisation;
- Review SIOPE financial management and scrutiny of annual accounts;
- Provide expert input on scientific policy and management issues.
The Board is led by the President and is composed of the President Elect or Past President (depending on the term), the Treasurer, the SIOPE Chief Executive Officer, the SIOPE Clinical Research Council Chairs and a certain number of other Board Members (currently 11), each with a know-how in a specific field. Board members are either elected by the General Assembly or appointed by the Board – because of their particular expertise – for a three-year term, renewable for only one consecutive term. The work of the Board is supported by the SIOPE Office.